The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. [electronic resource]
Producer: 19950726Description: 218-27 p. digitalISSN:- 0022-3042
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.